LBA27 Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC
暂无分享，去创建一个
E. Van Cutsem | A. Cercek | T. Bekaii-Saab | H. Lenz | P. Kasi | K. Ciombor | J. Strickler | D. Bajor | A. Kardosh | J. Hubbard | A. Coveler | M. Stecher | C. Fountzilas | W. Feng | A. Paulson | C. Wu | T. André | S. Siena | M. Fernandez | K. Ng